Health and Financial Impact on the Use of a Personal Exoskeleton in the Home and Community: a Case Study

NCT ID: NCT07030322

Last Updated: 2025-08-07

Basic Information

• Recruitment Status: ENROLLING_BY_INVITATION
• Total Enrollment: 5 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-08-04
• Study Completion Date: 2027-09-30

Brief Summary

The goal of this clinical trial is to examine the long-term use of a personal overground robotic exoskeleton in subjects with spinal cord injury. The main aims of this study include:

1. Determine patterns of personal overground robotic exoskeleton use over 12 months.

2. Examine the impact of personal overground robotic exoskeleton use on health outcomes over 12 months. These will include:

1. Objective health - heart rate, physical activity, sleep behavior, body temperature, body-mass index, and bone density

2. Medical status - rehospitalization, infection frequency, pressure injury, falls, fractures, medication (type/dose)

3. Function - bowel function, bladder function, pain, spasticity, quality of life, mental health, social participation

3. Determine healthcare expenditure over 12 months

Participants and their support person(s) will be trained on using a personal robotic exoskeleton in their home and community. Once they complete training, they will use the exoskeleton as they wish (ie, no requirement to use the device a certain number of times per week) and data collection will begin.

Detailed Description

This prospective observational study will recruit and enroll individuals with SCI. These individuals will be part of a convenience sample due to employment or volunteer work with Ekso Bionics. They will be own or have access to an Indego Personal exoskeleton for home use. The parallel mixed methods design will allow for quantitative and qualitative data collected concurrently and integrated with equal consideration. Eligible individuals will be identified through work with representatives at Ekso Bionics for device acquisition and set up of training. Individuals who acquire a personal device will be screened for eligibility (criteria detailed below) and qualifying patients will be approached to participate. Upon providing consent, participants will complete quantitative and qualitative assessments over 12 months. Assessments will be conducted on five occasions: (1) baseline, (2) 1-month post-enrollment, (3) 3-months post-enrollment, (4) 6-months post-enrollment, and (5) 12-months post-enrollment. All study specific assessments will be completed by trained assessors. Quantitative and qualitative assessments will be completed by a physical therapist or other member of the research staff with necessary training. Time commitment for each participant at each assessment is 60 to 90 minutes.

Additionally, participants will be fitted for and provided at study enrollment with a wearable medical monitoring device for continuous tracking over 12-months. Study staff will provide each participant with a personal device account, to be set up using a premade study email, during enrollment. These emails will be generated utilizing a unique identifier feature which allows a single email to be suffixed with a unique identifier (e.g., study email account: "EksoIndegoStudy@gmail.com", participant S001 Wearable sensor account: "EksoIndegoStudy+S001@gmail.com"). Each account will be linked to a research data collection platform at Ekso Bionics. Ekso Bionics will collect necessary data from the wearable sensors including: heart rate, physical activity, sleep data, stress scores, weight, and profile information. To maintain blinding of potential health data, we will use the 1st of the birth month for each participant, so activity levels based on age can still be calculated appropriately. Data from the wearable device will be retrieved from the manufacturer cloud-based storage. All data is available for export by study staff either individually or as batch data, including all de-identified participant data in one file.

No specific intervention will take place during this observational study. However, each will have access to an Ekso Indego Personal device for home and community use. The Ekso Indego Personal (Indego) is a wearable powered exoskeleton device that actively assists individuals to stand and walk; these are individuals with walking impairments resulting from lower extremity weakness or paralysis due to spinal cord injury. Unique in design, the Indego consists of five (5) snap-together components (the lumbar/hip section, right and left upper leg sections, and right and left lower leg sections). The hip component houses a rechargeable battery pack, while each upper leg component houses two motors as well as embedded sensors and controllers. The Ekso Indego Personal incorporates powered movement of both hip and knee joints, in addition to built-in ankle-foot-orthoses (AFOs) at both ankle joints, which provide ankle support and stability, and also transfers the weight of the exoskeleton to the ground. The Ekso Indego Personal requires use of a stability aid, such as a rolling walker or set of forearm crutches. Once acquired, participants will complete device training and utilize their personal Ekso Indego exoskeleton according to their individual preferences with their certified support person.

Assessments will include: brief usage survey, 1-1 focused interview on device usage, device data, objective health data captured by wearable health monitor, self-reported BMI, bone mineral density, medical status questionnaire, Modified International SCI Lower Urinary Tract Function Basic Data Set, Modified International SCI Bowl Function Basic Data Set, pain questionnaire, Penn Spasm Frequency Scale, quality of life questionnaire, General Anxiety Disorder-7, Craig Handicap Assessment And Reporting Technique, health encounters survey, 1-1 focused interview on healthcare encounters, and medical records review.

Conditions

Spinal Cord Injury

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Subjects with spinal cord Injury (SCI) who have a personal overground robotic exoskeleton device

Adults with a medical diagnosis of a spinal cord injury and sufficient upper extremity strength to manage approved stability aids (crutches, walker) who have access to a robotic exoskeleton device (Ekso Indego Personal) for use at home and in the community.

Overground Robotic Exoskeleton

Intervention Type: DEVICE

Participants will have received training on their personal exoskeleton device prior to data collection. There is no required use dosage of the Ekso Indego Personal for this observational study.

Interventions

Overground Robotic Exoskeleton

Participants will have received training on their personal exoskeleton device prior to data collection. There is no required use dosage of the Ekso Indego Personal for this observational study.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Femur lengths from 14.5" to 19" (35.5cm to 47 cm)
• Healthy bone density
• Height from 5'1" to 6'3" (1.5 to 1.9 m)
• Seated hip width ≤ 16.6" (42.2 cm)
• Sufficient upper extremity strength to manage approved stability aids
• Weight 250 lbs or less
• Availability of a support person able to complete training and be present during all Indego sessions

Exclusion Criteria

• Cognitive impairments resulting in inability to follow directions
• Colostomy bag
• Diminished standing tolerance caused by orthostatic hypotension
• Heterotopic ossification
• Hip or knee contractures greater than 10° or ankle contractures greater than 5°
• History of severe neurological injuries other than SCI (multiple sclerosis, --cerebral palsy, amyotrophic lateral sclerosis, traumatic brain injury, etc).
• Lower limb prothesis
• Poor skin integrity in areas in contact with the device
• Pregnancy
• Psychiatric conditions that may interfere with proper operation of the device
• Severe concurrent medical diseases: infections, circulatory, heart or lung, pressure sores
• Severe or uncontrolled spasticity (Modified Ashworth 4)
• Spinal instability or spinal orthotics
• Uncontrolled autonomic dysreflexia
• Uncontrolled hypertension or hypotension
• Unhealed limb or pelvic fractures
• Unresolved deep vein thrombosis
• Any condition which in the opinion of a medical doctor prevents the user from using the device

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Ekso Bionics

INDUSTRY

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Ekso Bionics, Inc.

San Rafael, California, United States

Countries

United States

References

Gorman PH, Forrest GF, Asselin PK, Scott W, Kornfeld S, Hong E, Spungen AM. The Effect of Exoskeletal-Assisted Walking on Spinal Cord Injury Bowel Function: Results from a Randomized Trial and Comparison to Other Physical Interventions. J Clin Med. 2021 Mar 2;10(5):964. doi: 10.3390/jcm10050964.

Reference Type: BACKGROUND

PMID: 33801165 (View on PubMed)

Baunsgaard CB, Nissen UV, Brust AK, Frotzler A, Ribeill C, Kalke YB, Leon N, Gomez B, Samuelsson K, Antepohl W, Holmstrom U, Marklund N, Glott T, Opheim A, Penalva JB, Murillo N, Nachtegaal J, Faber W, Biering-Sorensen F. Exoskeleton gait training after spinal cord injury: An exploratory study on secondary health conditions. J Rehabil Med. 2018 Sep 28;50(9):806-813. doi: 10.2340/16501977-2372.

Reference Type: BACKGROUND

PMID: 30183055 (View on PubMed)

Priebe MM, Sherwood AM, Thornby JI, Kharas NF, Markowski J. Clinical assessment of spasticity in spinal cord injury: a multidimensional problem. Arch Phys Med Rehabil. 1996 Jul;77(7):713-6. doi: 10.1016/s0003-9993(96)90014-3.

Reference Type: BACKGROUND

PMID: 8670001 (View on PubMed)

Hsieh JT, Wolfe DL, Miller WC, Curt A; SCIRE Research Team. Spasticity outcome measures in spinal cord injury: psychometric properties and clinical utility. Spinal Cord. 2008 Feb;46(2):86-95. doi: 10.1038/sj.sc.3102125. Epub 2007 Oct 2.

Reference Type: BACKGROUND

PMID: 17909559 (View on PubMed)

Krogh K, Emmanuel A, Perrouin-Verbe B, Korsten MA, Mulcahey MJ, Biering-Sorensen F. International spinal cord injury bowel function basic data set (Version 2.0). Spinal Cord. 2017 Jul;55(7):692-698. doi: 10.1038/sc.2016.189. Epub 2017 Feb 14.

Reference Type: BACKGROUND

PMID: 28195229 (View on PubMed)

Biering-Sorensen F, Kennelly M, Kessler TM, Linsenmeyer T, Pannek J, Vogel L, Wyndaele JJ. International Spinal Cord Injury Lower Urinary Tract Function Basic Data Set (version 2.0). Spinal Cord Ser Cases. 2018 Jul 6;4:60. doi: 10.1038/s41394-018-0090-7. eCollection 2018.

Reference Type: BACKGROUND

PMID: 30002915 (View on PubMed)

Shackleton C, Evans R, West S, Derman W, Albertus Y. Robotic Walking to Mitigate Bone Mineral Density Decline and Adverse Body Composition in Individuals With Incomplete Spinal Cord Injury: A Pilot Randomized Clinical Trial. Am J Phys Med Rehabil. 2022 Oct 1;101(10):931-936. doi: 10.1097/PHM.0000000000001937. Epub 2021 Dec 6.

Reference Type: BACKGROUND

PMID: 34864766 (View on PubMed)

Abdelrahman S, Ireland A, Winter EM, Purcell M, Coupaud S. Osteoporosis after spinal cord injury: aetiology, effects and therapeutic approaches. J Musculoskelet Neuronal Interact. 2021 Mar 1;21(1):26-50.

Reference Type: BACKGROUND

PMID: 33657753 (View on PubMed)

Cahill A, Ginley OM, Bertrand C, Lennon O. Gym-based exoskeleton walking: A preliminary exploration of non-ambulatory end-user perspectives. Disabil Health J. 2018 Jul;11(3):478-485. doi: 10.1016/j.dhjo.2018.01.004. Epub 2018 Feb 1.

Reference Type: BACKGROUND

PMID: 29500092 (View on PubMed)

van Dijsseldonk RB, van Nes IJW, Geurts ACH, Keijsers NLW. Exoskeleton home and community use in people with complete spinal cord injury. Sci Rep. 2020 Sep 24;10(1):15600. doi: 10.1038/s41598-020-72397-6.

Reference Type: BACKGROUND

PMID: 32973244 (View on PubMed)

Sikka S, Callender L, Driver S, Bennett M, Reynolds M, Hamilton R, Warren AM, Petrey L. Healthcare utilization following spinal cord injury: Objective findings from a regional hospital registry. J Spinal Cord Med. 2019 Mar;42(2):194-200. doi: 10.1080/10790268.2018.1505330. Epub 2018 Oct 2.

Reference Type: BACKGROUND

PMID: 30277845 (View on PubMed)

Skelton F, Hoffman JM, Reyes M, Burns SP. Examining health-care utilization in the first year following spinal cord injury. J Spinal Cord Med. 2015 Nov;38(6):690-5. doi: 10.1179/2045772314Y.0000000269. Epub 2014 Oct 9.

Reference Type: BACKGROUND

PMID: 25299152 (View on PubMed)

Stillman MD, Frost KL, Smalley C, Bertocci G, Williams S. Health care utilization and barriers experienced by individuals with spinal cord injury. Arch Phys Med Rehabil. 2014 Jun;95(6):1114-26. doi: 10.1016/j.apmr.2014.02.005. Epub 2014 Feb 22.

Reference Type: BACKGROUND

PMID: 24565745 (View on PubMed)

Cardenas DD, Hoffman JM, Kirshblum S, McKinley W. Etiology and incidence of rehospitalization after traumatic spinal cord injury: a multicenter analysis. Arch Phys Med Rehabil. 2004 Nov;85(11):1757-63. doi: 10.1016/j.apmr.2004.03.016.

Reference Type: BACKGROUND

PMID: 15520970 (View on PubMed)

Fogelberg D, Atkins M, Blanche EI, Carlson M, Clark F. Decisions and Dilemmas in Everyday Life: Daily Use of Wheelchairs by Individuals with Spinal Cord Injury and the Impact on Pressure Ulcer Risk. Top Spinal Cord Inj Rehabil. 2009 Fall;15(2):16-32. doi: 10.1310/sci1502-16.

Reference Type: BACKGROUND

PMID: 21603085 (View on PubMed)

Jensen MP, Truitt AR, Schomer KG, Yorkston KM, Baylor C, Molton IR. Frequency and age effects of secondary health conditions in individuals with spinal cord injury: a scoping review. Spinal Cord. 2013 Dec;51(12):882-92. doi: 10.1038/sc.2013.112. Epub 2013 Oct 15.

Reference Type: BACKGROUND

PMID: 24126851 (View on PubMed)

Louie DR, Eng JJ, Lam T; Spinal Cord Injury Research Evidence (SCIRE) Research Team. Gait speed using powered robotic exoskeletons after spinal cord injury: a systematic review and correlational study. J Neuroeng Rehabil. 2015 Oct 14;12:82. doi: 10.1186/s12984-015-0074-9.

Reference Type: BACKGROUND

PMID: 26463355 (View on PubMed)

Tefertiller C, Hays K, Jones J, Jayaraman A, Hartigan C, Bushnik T, Forrest GF. Initial Outcomes from a Multicenter Study Utilizing the Indego Powered Exoskeleton in Spinal Cord Injury. Top Spinal Cord Inj Rehabil. 2018 Winter;24(1):78-85. doi: 10.1310/sci17-00014. Epub 2017 Nov 20.

Reference Type: BACKGROUND

PMID: 29434463 (View on PubMed)

Sale P, Franceschini M, Waldner A, Hesse S. Use of the robot assisted gait therapy in rehabilitation of patients with stroke and spinal cord injury. Eur J Phys Rehabil Med. 2012 Mar;48(1):111-21.

Reference Type: BACKGROUND

PMID: 22543557 (View on PubMed)

Chen G, Chan CK, Guo Z, Yu H. A review of lower extremity assistive robotic exoskeletons in rehabilitation therapy. Crit Rev Biomed Eng. 2013;41(4-5):343-63. doi: 10.1615/critrevbiomedeng.2014010453.

Reference Type: BACKGROUND

PMID: 24941413 (View on PubMed)

Esquenazi A, Talaty M, Jayaraman A. Powered Exoskeletons for Walking Assistance in Persons with Central Nervous System Injuries: A Narrative Review. PM R. 2017 Jan;9(1):46-62. doi: 10.1016/j.pmrj.2016.07.534. Epub 2016 Aug 24.

Reference Type: BACKGROUND

PMID: 27565639 (View on PubMed)

Mekki M, Delgado AD, Fry A, Putrino D, Huang V. Robotic Rehabilitation and Spinal Cord Injury: a Narrative Review. Neurotherapeutics. 2018 Jul;15(3):604-617. doi: 10.1007/s13311-018-0642-3.

Reference Type: BACKGROUND

PMID: 29987763 (View on PubMed)

Mehrholz J, Pohl M. Electromechanical-assisted gait training after stroke: a systematic review comparing end-effector and exoskeleton devices. J Rehabil Med. 2012 Mar;44(3):193-9. doi: 10.2340/16501977-0943.

Reference Type: BACKGROUND

PMID: 22378603 (View on PubMed)

Other Identifiers

1385701

Identifier Type: -

Identifier Source: org_study_id